{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:51:29Z","timestamp":1787003489310,"version":"build-2736575974"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T00:00:00Z","timestamp":1671235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T00:00:00Z","timestamp":1671235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"German Research Foundation (DFG), SteaPKMod","award":["410848700"],"award-info":[{"award-number":["410848700"]}]},{"name":"German Research Foundation (DFG), QuaLiPerF","award":["436883643"],"award-info":[{"award-number":["436883643"]}]},{"DOI":"10.13039\/501100002347","name":"Federal Ministry of Education and Research","doi-asserted-by":"crossref","award":["031L0054"],"award-info":[{"award-number":["031L0054"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"crossref"}]},{"name":"German Research Foundation (DFG), SimLivA","award":["465194077"],"award-info":[{"award-number":["465194077"]}]},{"DOI":"10.13039\/501100007653","name":"Universit\u00e4tsklinikum Jena","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007653","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Little is known about the impact of morphological disorders in distinct zones on metabolic zonation. It was described recently that periportal fibrosis did affect the expression of CYP proteins, a set of pericentrally located drug-metabolizing enzymes. Here, we investigated whether periportal steatosis might have a similar effect. Periportal steatosis was induced in C57BL6\/J mice by feeding a high-fat diet with low methionine\/choline content for either two or four weeks. Steatosis severity was quantified using image analysis. Triglycerides and CYP activity were quantified in photometric or fluorometric assay. The distribution of CYP3A4, CYP1A2, CYP2D6, and CYP2E1 was visualized by immunohistochemistry. Pharmacokinetic parameters of test drugs were determined after injecting a drug cocktail (caffeine, codeine, and midazolam). The dietary model resulted in moderate to severe mixed steatosis confined to periportal and midzonal areas. Periportal steatosis did not affect the zonal distribution of CYP expression but the activity of selected CYPs was associated with steatosis severity. Caffeine elimination was accelerated by microvesicular steatosis, whereas midazolam elimination was delayed in macrovesicular steatosis. In summary, periportal steatosis affected parameters of pericentrally located drug metabolism. This observation calls for further investigations of the highly complex interrelationship between steatosis and drug metabolism and underlying signaling mechanisms.<\/jats:p>","DOI":"10.1038\/s41598-022-26483-6","type":"journal-article","created":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T06:03:49Z","timestamp":1671257029000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Periportal steatosis in mice affects distinct parameters of pericentral drug metabolism"],"prefix":"10.1038","volume":"12","author":[{"given":"Mohamed","family":"Albadry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"H\u00f6pfl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Ehteshamzad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"K\u00f6nig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"B\u00f6ttcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasna","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelie","family":"Lupp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf","family":"Dirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Radde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Christ","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madlen","family":"Christ","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars Ole","family":"Schwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik","family":"Laue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Klopfleisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3483-3388","authenticated-orcid":false,"given":"Uta","family":"Dahmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,17]]},"reference":[{"key":"26483_CR1","unstructured":"Garza, A. Z., Park, S. B. & Kocz, R. Drug elimination. [Updated 2022 Jul 11]. In: StatPearls [Internet]. (StatPearls Publishing, 2022). https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK547662\/."},{"key":"26483_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cld.2016.08.001","volume":"21","author":"OA Almazroo","year":"2017","unstructured":"Almazroo, O. A., Miah, M. K. & Venkataramanan, R. Drug metabolism in the liver. Clin. Liver Dis. 21, 1. https:\/\/doi.org\/10.1016\/j.cld.2016.08.001 (2017).","journal-title":"Clin. Liver Dis."},{"key":"26483_CR3","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/s0306-3623(96)00183-8","volume":"28","author":"KO Lindros","year":"1997","unstructured":"Lindros, K. O. Zonation of cytochrome P450 expression, drug metabolism and toxicity in liver. Gen. Pharmacol. 28, 191\u2013196. https:\/\/doi.org\/10.1016\/s0306-3623(96)00183-8 (1997).","journal-title":"Gen. Pharmacol."},{"key":"26483_CR4","doi-asserted-by":"crossref","unstructured":"Colnot, S. & Perret, C. In Molecular Pathology of Liver Diseases 7\u201316 (Springer, 2011).","DOI":"10.1007\/978-1-4419-7107-4_2"},{"key":"26483_CR5","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1177\/1535370217707731","volume":"242","author":"A Soto-Gutierrez","year":"2017","unstructured":"Soto-Gutierrez, A., Gough, A., Vernetti, L. A., Taylor, D. L. & Monga, S. P. Pre-clinical and clinical investigations of metabolic zonation in liver diseases: The potential of microphysiology systems. Exp. Biol. Med. (Maywood) 242, 1605\u20131616. https:\/\/doi.org\/10.1177\/1535370217707731 (2017).","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"26483_CR6","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.redox.2017.01.012","volume":"11","author":"T Kietzmann","year":"2017","unstructured":"Kietzmann, T. Metabolic zonation of the liver: The oxygen gradient revisited. Redox Biol. 11, 622\u2013630. https:\/\/doi.org\/10.1016\/j.redox.2017.01.012 (2017).","journal-title":"Redox Biol."},{"key":"26483_CR7","doi-asserted-by":"publisher","first-page":"8491","DOI":"10.3748\/wjg.v20.i26.8491","volume":"20","author":"R Gebhardt","year":"2014","unstructured":"Gebhardt, R. & Matz-Soja, M. Liver zonation: Novel aspects of its regulation and its impact on homeostasis. World J. Gastroenterol. 20, 8491\u20138504. https:\/\/doi.org\/10.3748\/wjg.v20.i26.8491 (2014).","journal-title":"World J. Gastroenterol."},{"key":"26483_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/cells8121556","author":"A Ghallab","year":"2019","unstructured":"Ghallab, A. et al. Influence of liver fibrosis on lobular zonation. Cells https:\/\/doi.org\/10.3390\/cells8121556 (2019).","journal-title":"Cells"},{"key":"26483_CR9","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1016\/s0016-5085(96)70028-8","volume":"111","author":"MD Weltman","year":"1996","unstructured":"Weltman, M. D., Farrell, G. C. & Liddle, C. Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation. Gastroenterology 111, 1645\u20131653. https:\/\/doi.org\/10.1016\/s0016-5085(96)70028-8 (1996).","journal-title":"Gastroenterology"},{"key":"26483_CR10","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1097\/SLA.0b013e3181dbb572","volume":"251","author":"LN Bell","year":"2010","unstructured":"Bell, L. N. et al. Bariatric surgery-induced weight loss reduces hepatic lipid peroxidation levels and affects hepatic cytochrome P-450 protein content. Ann. Surg. 251, 1041\u20131048. https:\/\/doi.org\/10.1097\/SLA.0b013e3181dbb572 (2010).","journal-title":"Ann. Surg."},{"key":"26483_CR11","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.lfs.2010.01.011","volume":"86","author":"S Hata","year":"2010","unstructured":"Hata, S. et al. Cytochrome 3A and 2E1 in human liver tissue: Individual variations among normal Japanese subjects. Life Sci. 86, 393\u2013401. https:\/\/doi.org\/10.1016\/j.lfs.2010.01.011 (2010).","journal-title":"Life Sci."},{"key":"26483_CR12","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/s0168-8278(03)00360-x","volume":"39","author":"P St\u00e4rkel","year":"2003","unstructured":"St\u00e4rkel, P. et al. Oxidative stress, KLF6 and transforming growth factor-beta up-regulation differentiate non-alcoholic steatohepatitis progressing to fibrosis from uncomplicated steatosis in rats. J. Hepatol. 39, 538\u2013546. https:\/\/doi.org\/10.1016\/s0168-8278(03)00360-x (2003).","journal-title":"J. Hepatol."},{"key":"26483_CR13","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3748\/wjg.v23.i2.204","volume":"23","author":"T Kostrzewski","year":"2017","unstructured":"Kostrzewski, T. et al. Three-dimensional perfused human in vitro model of non-alcoholic fatty liver disease. World J. Gastroenterol. 23, 204\u2013215. https:\/\/doi.org\/10.3748\/wjg.v23.i2.204 (2017).","journal-title":"World J. Gastroenterol."},{"key":"26483_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.112377","volume":"146","author":"C Rey-Bedon","year":"2022","unstructured":"Rey-Bedon, C. et al. CYP450 drug inducibility in NAFLD via an in vitro hepatic model: Understanding drug\u2013drug interactions in the fatty liver. Biomed. Pharmacother. 146, 112377. https:\/\/doi.org\/10.1016\/j.biopha.2021.112377 (2022).","journal-title":"Biomed. Pharmacother."},{"key":"26483_CR15","doi-asserted-by":"publisher","first-page":"10180","DOI":"10.3748\/wjg.v22.i46.10180","volume":"22","author":"W Jiang","year":"2016","unstructured":"Jiang, W., Guo, M. H. & Hai, X. Hepatoprotective and antioxidant effects of lycopene on non-alcoholic fatty liver disease in rat. World J. Gastroenterol. 22, 10180\u201310188. https:\/\/doi.org\/10.3748\/wjg.v22.i46.10180 (2016).","journal-title":"World J. Gastroenterol."},{"key":"26483_CR16","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1002\/hep.510270121","volume":"27","author":"MD Weltman","year":"1998","unstructured":"Weltman, M. D., Farrell, G. C., Hall, P., Ingelman-Sundberg, M. & Liddle, C. Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis. Hepatology 27, 128\u2013133 (1998).","journal-title":"Hepatology"},{"key":"26483_CR17","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1124\/dmd.109.027466","volume":"37","author":"CD Fisher","year":"2009","unstructured":"Fisher, C. D. et al. Hepatic cytochrome P450 enzyme alterations in humans with progressive stages of nonalcoholic fatty liver disease. Drug Metab. Dispos. 37, 2087\u20132094. https:\/\/doi.org\/10.1124\/dmd.109.027466 (2009).","journal-title":"Drug Metab. Dispos."},{"key":"26483_CR18","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1080\/03602532.2017.1293683","volume":"49","author":"E Cobbina","year":"2017","unstructured":"Cobbina, E. & Akhlaghi, F. Non-alcoholic fatty liver disease (NAFLD)\u2014Pathogenesis, classification, and effect on drug metabolizing enzymes and transporters. Drug Metab. Rev. 49, 197\u2013211. https:\/\/doi.org\/10.1080\/03602532.2017.1293683 (2017).","journal-title":"Drug Metab. Rev."},{"key":"26483_CR19","doi-asserted-by":"publisher","first-page":"6224","DOI":"10.1038\/s41598-017-04574-z","volume":"7","author":"A Schenk","year":"2017","unstructured":"Schenk, A. et al. Physiologically-based modelling in mice suggests an aggravated loss of clearance capacity after toxic liver damage. Sci. Rep. 7, 6224. https:\/\/doi.org\/10.1038\/s41598-017-04574-z (2017).","journal-title":"Sci. Rep."},{"key":"26483_CR20","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.semcdb.2020.04.011","volume":"108","author":"F Seebacher","year":"2020","unstructured":"Seebacher, F., Zeigerer, A., Kory, N. & Krahmer, N. Hepatic lipid droplet homeostasis and fatty liver disease. Semin. Cell Dev. Biol. 108, 72\u201381. https:\/\/doi.org\/10.1016\/j.semcdb.2020.04.011 (2020).","journal-title":"Semin. Cell Dev. Biol."},{"key":"26483_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2020.101115","author":"DG Mashek","year":"2020","unstructured":"Mashek, D. G. Hepatic lipid droplets: A balancing act between energy storage and metabolic dysfunction in NAFLD. Mol. Metab. https:\/\/doi.org\/10.1016\/j.molmet.2020.101115 (2020).","journal-title":"Mol. Metab."},{"issue":"Suppl 1","key":"26483_CR22","doi-asserted-by":"publisher","first-page":"S40","DOI":"10.1038\/modpathol.3800680","volume":"20","author":"EM Brunt","year":"2007","unstructured":"Brunt, E. M. Pathology of fatty liver disease. Mod. Pathol. 20(Suppl 1), S40-48. https:\/\/doi.org\/10.1038\/modpathol.3800680 (2007).","journal-title":"Mod. Pathol."},{"key":"26483_CR23","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.compbiomed.2016.04.004","volume":"73","author":"LO Schwen","year":"2016","unstructured":"Schwen, L. O. et al. Zonated quantification of steatosis in an entire mouse liver. Comput. Biol. Med. 73, 108\u2013118. https:\/\/doi.org\/10.1016\/j.compbiomed.2016.04.004 (2016).","journal-title":"Comput. Biol. Med."},{"key":"26483_CR24","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13000-018-0753-5","volume":"13","author":"A Homeyer","year":"2018","unstructured":"Homeyer, A. et al. Focused scores enable reliable discrimination of small differences in steatosis. Diagn. Pathol. 13, 76. https:\/\/doi.org\/10.1186\/s13000-018-0753-5 (2018).","journal-title":"Diagn. Pathol."},{"key":"26483_CR25","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nrgastro.2017.32","volume":"14","author":"NL Gluchowski","year":"2017","unstructured":"Gluchowski, N. L., Becuwe, M., Walther, T. C. & Farese, R. V. Jr. Lipid droplets and liver disease: From basic biology to clinical implications. Nat. Rev. Gastroenterol. Hepatol. 14, 343\u2013355. https:\/\/doi.org\/10.1038\/nrgastro.2017.32 (2017).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"26483_CR26","unstructured":"Sun, J. Induction of fatty liver in Lewis rats using different diets Doctor\u2019s Degree of Medicine thesis, University of Duisburg-Essen (2011)."},{"key":"26483_CR27","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1159\/000501851","volume":"101","author":"F Zhong","year":"2020","unstructured":"Zhong, F., Zhou, X., Xu, J. & Gao, L. Rodent models of nonalcoholic fatty liver disease. Digestion 101, 522\u2013535. https:\/\/doi.org\/10.1159\/000501851 (2020).","journal-title":"Digestion"},{"key":"26483_CR28","doi-asserted-by":"publisher","first-page":"789","DOI":"10.5604\/16652681.1171749","volume":"14","author":"SK Satapathy","year":"2015","unstructured":"Satapathy, S. K., Kuwajima, V., Nadelson, J., Atiq, O. & Sanyal, A. J. Drug-induced fatty liver disease: An overview of pathogenesis and management. Ann. Hepatol. 14, 789\u2013806. https:\/\/doi.org\/10.5604\/16652681.1171749 (2015).","journal-title":"Ann. Hepatol."},{"key":"26483_CR29","first-page":"86","volume":"21","author":"L Miele","year":"2017","unstructured":"Miele, L. et al. Fatty liver and drugs: the two sides of the same coin. Eur. Rev. Med. Pharmacol. Sci. 21, 86\u201394 (2017).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"26483_CR30","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.livres.2019.06.001","volume":"3","author":"B Fromenty","year":"2019","unstructured":"Fromenty, B. Inhibition of mitochondrial fatty acid oxidation in drug-induced hepatic steatosis. Liver Res. 3, 157\u2013169 (2019).","journal-title":"Liver Res."},{"key":"26483_CR31","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1590\/S1516-31802011000400004","volume":"129","author":"GH Silva","year":"2011","unstructured":"Silva, G. H., Hessel, G., Coelho, K. I. R. & Escanhoela, C. A. F. Steatosis of indeterminate cause in a pediatric group: Is it a primary mitochondrial hepatopathy?. Sao Paulo Med. J. 129, 217\u2013223. https:\/\/doi.org\/10.1590\/S1516-31802011000400004 (2011).","journal-title":"Sao Paulo Med. J."},{"key":"26483_CR32","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.cmpb.2015.05.009","volume":"121","author":"A Homeyer","year":"2015","unstructured":"Homeyer, A. et al. Fast and accurate identification of fat droplets in histological images. Comput. Methods Progr. Biomed. 121, 59\u201365. https:\/\/doi.org\/10.1016\/j.cmpb.2015.05.009 (2015).","journal-title":"Comput. Methods Progr. Biomed."},{"key":"26483_CR33","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.humpath.2003.10.029","volume":"35","author":"H Marsman","year":"2004","unstructured":"Marsman, H. et al. Assessment of donor liver steatosis: Pathologist or automated software?. Hum. Pathol. 35, 430\u2013435. https:\/\/doi.org\/10.1016\/j.humpath.2003.10.029 (2004).","journal-title":"Hum. Pathol."},{"key":"26483_CR34","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1002\/lt.23615","volume":"19","author":"H Yersiz","year":"2013","unstructured":"Yersiz, H. et al. Assessment of hepatic steatosis by transplant surgeon and expert pathologist: A prospective, double-blind evaluation of 201 donor livers. Liver Transplant. 19, 437\u2013449. https:\/\/doi.org\/10.1002\/lt.23615 (2013).","journal-title":"Liver Transplant."},{"key":"26483_CR35","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1109\/jbhi.2013.2282999","volume":"18","author":"D Meihong","year":"2014","unstructured":"Meihong, D. et al. Limited correlation between conventional pathologist and automatic computer-assisted quantification of hepatic steatosis due to difference between event-based and surface-based analysis. IEEE J. Biomed. Health 18, 1473\u20131477. https:\/\/doi.org\/10.1109\/jbhi.2013.2282999 (2014).","journal-title":"IEEE J. Biomed. Health"},{"key":"26483_CR36","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner, D. E. et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41, 1313\u20131321. https:\/\/doi.org\/10.1002\/hep.20701 (2005).","journal-title":"Hepatology"},{"key":"26483_CR37","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.bcp.2019.05.002","volume":"164","author":"L Zhang","year":"2019","unstructured":"Zhang, L. et al. Diet-induced obese alters the expression and function of hepatic drug-metabolizing enzymes and transporters in rats. Biochem. Pharmacol. 164, 368\u2013376. https:\/\/doi.org\/10.1016\/j.bcp.2019.05.002 (2019).","journal-title":"Biochem. Pharmacol."},{"key":"26483_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.21840","volume":"31","author":"H Li","year":"2017","unstructured":"Li, H. et al. In vivo cytochrome P450 activity alterations in diabetic nonalcoholic steatohepatitis mice. J. Biochem. Mol. Toxicol. 31, e21840. https:\/\/doi.org\/10.1002\/jbt.21840 (2017).","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"26483_CR39","doi-asserted-by":"publisher","first-page":"4134","DOI":"10.1021\/acs.jproteome.7b00505","volume":"16","author":"R Jamwal","year":"2017","unstructured":"Jamwal, R. et al. Multiplex and label-free relative quantification approach for studying protein abundance of drug metabolizing enzymes in human liver microsomes using SWATH-MS. J. Proteome Res. 16, 4134\u20134143. https:\/\/doi.org\/10.1021\/acs.jproteome.7b00505 (2017).","journal-title":"J. Proteome Res."},{"key":"26483_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/cells11020288","author":"J Massart","year":"2022","unstructured":"Massart, J., Begriche, K., Hartman, J. H. & Fromenty, B. Role of mitochondrial cytochrome P450 2E1 in healthy and diseased liver. Cells https:\/\/doi.org\/10.3390\/cells11020288 (2022).","journal-title":"Cells"},{"key":"26483_CR41","doi-asserted-by":"publisher","first-page":"825","DOI":"10.21037\/jtd.2017.12.106","volume":"10","author":"XB Zhang","year":"2018","unstructured":"Zhang, X. B. et al. Decreased expression of hepatic cytochrome P450 1A2 (CYP1A2) in a chronic intermittent hypoxia mouse model. J. Thorac. Dis. 10, 825\u2013834. https:\/\/doi.org\/10.21037\/jtd.2017.12.106 (2018).","journal-title":"J. Thorac. Dis."},{"key":"26483_CR42","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1124\/dmd.115.065979","volume":"43","author":"SJ Woolsey","year":"2015","unstructured":"Woolsey, S. J., Mansell, S. E., Kim, R. B., Tirona, R. G. & Beaton, M. D. CYP3A activity and expression in nonalcoholic fatty liver disease. Drug Metab. Dispos. 43, 1484\u20131490. https:\/\/doi.org\/10.1124\/dmd.115.065979 (2015).","journal-title":"Drug Metab. Dispos."},{"key":"26483_CR43","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.cgh.2006.12.021","volume":"5","author":"D Kolwankar","year":"2007","unstructured":"Kolwankar, D. et al. Association between nonalcoholic hepatic steatosis and hepatic cytochrome P-450 3A activity. Clin. Gastroenterol. Hepatol. 5, 388\u2013393. https:\/\/doi.org\/10.1016\/j.cgh.2006.12.021 (2007).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"26483_CR44","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1053\/j.gastro.2005.11.017","volume":"130","author":"CP Day","year":"2006","unstructured":"Day, C. P. From fat to inflammation. Gastroenterology 130, 207\u2013210. https:\/\/doi.org\/10.1053\/j.gastro.2005.11.017 (2006).","journal-title":"Gastroenterology"},{"key":"26483_CR45","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2133\/dmpk.DMPK-10-RV-089","volume":"26","author":"TA Baillie","year":"2011","unstructured":"Baillie, T. A. & Rettie, A. E. Role of biotransformation in drug-induced toxicity: Influence of intra-and inter-species differences in drug metabolism. Drug Metab. Pharmacok. 26, 15\u201329. https:\/\/doi.org\/10.2133\/dmpk.DMPK-10-RV-089 (2011).","journal-title":"Drug Metab. Pharmacok."},{"key":"26483_CR46","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1124\/mol.107.043869","volume":"73","author":"RA van Waterschoot","year":"2008","unstructured":"van Waterschoot, R. A. et al. Midazolam metabolism in cytochrome P450 3A knockout mice can be attributed to up-regulated CYP2C enzymes. Mol. Pharmacol. 73, 1029\u20131036. https:\/\/doi.org\/10.1124\/mol.107.043869 (2008).","journal-title":"Mol. Pharmacol."},{"key":"26483_CR47","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1124\/dmd.117.079244","volume":"46","author":"M Tachikawa","year":"2018","unstructured":"Tachikawa, M. et al. Liver zonation index of drug transporter and metabolizing enzyme protein expressions in mouse liver acinus. Drug Metab. Dispos. 46, 610\u2013618. https:\/\/doi.org\/10.1124\/dmd.117.079244 (2018).","journal-title":"Drug Metab. Dispos."},{"key":"26483_CR48","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1515\/dmpt-2016-0008","volume":"31","author":"NM Kulkarni","year":"2016","unstructured":"Kulkarni, N. M. et al. Altered pharmacokinetics of rosiglitazone in a mouse model of non-alcoholic fatty liver disease. Drug. Metab. Pers. Ther. 31, 165\u2013171. https:\/\/doi.org\/10.1515\/dmpt-2016-0008 (2016).","journal-title":"Drug. Metab. Pers. Ther."},{"key":"26483_CR49","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1124\/dmd.107.015107","volume":"35","author":"AJ Lickteig","year":"2007","unstructured":"Lickteig, A. J. et al. Efflux transporter expression and acetaminophen metabolite excretion are altered in rodent models of nonalcoholic fatty liver disease. Drug Metab. Dispos. 35, 1970\u20131978. https:\/\/doi.org\/10.1124\/dmd.107.015107 (2007).","journal-title":"Drug Metab. Dispos."},{"key":"26483_CR50","doi-asserted-by":"publisher","first-page":"98","DOI":"10.18433\/jpps30268","volume":"22","author":"WS Bang","year":"2019","unstructured":"Bang, W. S., Hwang, Y. R., Li, Z., Lee, I. & Kang, H. E. Effects of orotic acid-induced non-alcoholic fatty liver on the pharmacokinetics of metoprolol and its metabolites in rats. J. Pharm. Pharm. Sci. 22, 98\u2013111. https:\/\/doi.org\/10.18433\/jpps30268 (2019).","journal-title":"J. Pharm. Pharm. Sci."},{"key":"26483_CR51","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s00204-019-02630-3","volume":"94","author":"G Campos","year":"2020","unstructured":"Campos, G. et al. Inflammation-associated suppression of metabolic gene networks in acute and chronic liver disease. Arch. Toxicol. 94, 205\u2013217. https:\/\/doi.org\/10.1007\/s00204-019-02630-3 (2020).","journal-title":"Arch. Toxicol."},{"key":"26483_CR52","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1055\/s-2007-1007106","volume":"19","author":"G Ramadori","year":"1999","unstructured":"Ramadori, G. & Christ, B. Cytokines and the hepatic acute-phase response. Semin. Liver Dis. 19, 141\u2013155. https:\/\/doi.org\/10.1055\/s-2007-1007106 (1999).","journal-title":"Semin. Liver Dis."},{"key":"26483_CR53","first-page":"600","volume":"50","author":"PV Turner","year":"2011","unstructured":"Turner, P. V., Brabb, T., Pekow, C. & Vasbinder, M. A. Administration of substances to laboratory animals: Routes of administration and factors to consider. J. Am. Assoc. Lab. Anim. Sci. 50, 600\u2013613 (2011).","journal-title":"J. Am. Assoc. Lab. Anim. Sci."},{"key":"26483_CR54","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0160-5402(82)90004-3","volume":"8","author":"U Kleeberg","year":"1982","unstructured":"Kleeberg, U. & Klinger, W. Sensitive formaldehyde determination with nashs reagent and a tryptophan reaction. J. Pharmacol. Method 8, 19\u201331. https:\/\/doi.org\/10.1016\/0160-5402(82)90004-3 (1982).","journal-title":"J. Pharmacol. Method"},{"key":"26483_CR55","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/0003-2697(78)90245-2","volume":"85","author":"A Aitio","year":"1978","unstructured":"Aitio, A. A simple and sensitive assay of 7-ethoxycoumarin deethylation. Anal. Biochem. 85, 488\u2013491. https:\/\/doi.org\/10.1016\/0003-2697(78)90245-2 (1978).","journal-title":"Anal. Biochem."},{"key":"26483_CR56","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/0003-2697(80)90505-9","volume":"107","author":"RJ Pohl","year":"1980","unstructured":"Pohl, R. J. & Fouts, J. R. A rapid method for assaying the metabolism of 7-ethoxyresorufin by microsomal subcellular fractions. Anal. Biochem. 107, 150\u2013155. https:\/\/doi.org\/10.1016\/0003-2697(80)90505-9 (1980).","journal-title":"Anal. Biochem."},{"key":"26483_CR57","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1385\/1-59259-998-2:127","volume":"320","author":"TK Chang","year":"2006","unstructured":"Chang, T. K., Crespi, C. L. & Waxman, D. J. Spectrophotometric analysis of human CYP2E1-catalyzed p-nitrophenol hydroxylation. Methods Mol. Biol. 320, 127\u2013131. https:\/\/doi.org\/10.1385\/1-59259-998-2:127 (2006).","journal-title":"Methods Mol. Biol."},{"key":"26483_CR58","unstructured":"Newville, M. et al. LMFIT: Non-linear least-square minimization and curve-fitting for Python. Astrophysics Source Code Library, ascl: 1606.1014 (2016)."},{"key":"26483_CR59","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41592-019-0686-2","volume":"17","author":"P Virtanen","year":"2020","unstructured":"Virtanen, P. et al. SciPy 1.0: Fundamental algorithms for scientific computing in Python. Nat. Methods 17, 261\u2013272. https:\/\/doi.org\/10.1038\/s41592-019-0686-2 (2020).","journal-title":"Nat. Methods"},{"key":"26483_CR60","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1093\/bioinformatics\/btg015","volume":"19","author":"M Hucka","year":"2003","unstructured":"Hucka, M. et al. The systems biology markup language (SBML): A medium for representation and exchange of biochemical network models. Bioinformatics 19, 524\u2013531. https:\/\/doi.org\/10.1093\/bioinformatics\/btg015 (2003).","journal-title":"Bioinformatics"},{"key":"26483_CR61","doi-asserted-by":"publisher","DOI":"10.15252\/msb.20199110","volume":"16","author":"SM Keating","year":"2020","unstructured":"Keating, S. M. et al. SBML Level 3: An extensible format for the exchange and reuse of biological models. Mol. Syst. Biol. 16, e9110. https:\/\/doi.org\/10.15252\/msb.20199110 (2020).","journal-title":"Mol. Syst. Biol."},{"key":"26483_CR62","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1008646","volume":"17","author":"L Schmiester","year":"2021","unstructured":"Schmiester, L. et al. PEtab-Interoperable specification of parameter estimation problems in systems biology. PLoS Comput. Biol. 17, e1008646. https:\/\/doi.org\/10.1371\/journal.pcbi.1008646 (2021).","journal-title":"PLoS Comput. Biol."},{"key":"26483_CR63","doi-asserted-by":"publisher","first-page":"3215","DOI":"10.21105\/joss.03215","volume":"6","author":"J Vanhoefer","year":"2021","unstructured":"Vanhoefer, J., Matos, M., Pathirana, D., Sch\u00e4lte, Y. & Hasenauer, J. yaml2sbml: Human-readable and -writable specification of ODE models and their conversion to SBML. J. Open Source Softw. 6, 3215. https:\/\/doi.org\/10.21105\/joss.03215 (2021).","journal-title":"J. Open Source Softw."},{"key":"26483_CR64","doi-asserted-by":"publisher","unstructured":"Sch\u00e4lte, Y. et al. pyPESTO\u2014Parameter EStimation TOolbox for python (0.2.7). https:\/\/doi.org\/10.5281\/zenodo.6606687 (2021).","DOI":"10.5281\/zenodo.6606687"},{"key":"26483_CR65","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1093\/mnras\/stv2422","volume":"455","author":"WD Vousden","year":"2016","unstructured":"Vousden, W. D., Farr, W. M. & Mandel, I. Dynamic temperature selection for parallel tempering in Markov chain Monte Carlo simulations. Mon. Not. R. Astron. Soc. 455, 1919\u20131937. https:\/\/doi.org\/10.1093\/mnras\/stv2422 (2016).","journal-title":"Mon. Not. R. Astron. Soc."},{"key":"26483_CR66","doi-asserted-by":"crossref","unstructured":"Geweke, J. F. Evaluating the accuracy of sampling-based approaches to the calculation of posterior moments. Report No. Staff Report 148, (Federal Reserve Bank of Minneapolis, 1991).","DOI":"10.21034\/sr.148"},{"key":"26483_CR67","doi-asserted-by":"publisher","first-page":"3676","DOI":"10.1093\/bioinformatics\/btab227","volume":"37","author":"F Fr\u00f6hlich","year":"2021","unstructured":"Fr\u00f6hlich, F. et al. AMICI: High-performance sensitivity analysis for large ordinary differential equation models. Bioinformatics 37, 3676\u20133677 (2021).","journal-title":"Bioinformatics"},{"key":"26483_CR68","first-page":"69","volume":"24","author":"MM Mukaka","year":"2012","unstructured":"Mukaka, M. M. Statistics Corner: A guide to appropriate use of Correlation coefficient in medical research. Malawi Med. J. 24, 69\u201371 (2012).","journal-title":"Malawi Med. J."},{"key":"26483_CR69","doi-asserted-by":"publisher","first-page":"D404","DOI":"10.1093\/nar\/gkw1032","volume":"45","author":"K Wolstencroft","year":"2017","unstructured":"Wolstencroft, K. et al. FAIRDOMHub: A repository and collaboration environment for sharing systems biology research. Nucleic Acids Res. 45, D404\u2013D407. https:\/\/doi.org\/10.1093\/nar\/gkw1032 (2017).","journal-title":"Nucleic Acids Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-26483-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-26483-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-26483-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T06:11:45Z","timestamp":1671516705000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-26483-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,17]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["26483"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-26483-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,17]]},"assertion":[{"value":"14 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21825"}}